PERSISTENT SYMPTOMS IN PATIENTS AFTER ACUTE COVID-19 INFECTION": A SINGLE CENTER EXPERIENCE: ARE WE DOING ENOUGH FOR THIS?

AZK CHACHAR; SR QURESHI; AH ALVI; M SOHAIB; S ALI; M ULFAT

doi:10.54112/bcsrj.v2023i1.561

Authors

AZK CHACHAR Department of Medicine, Fatima Memorial Hospital College of Medicine & Dentistry, Lahore, Pakistan
SR QURESHI Department of Gastroenterology, Fatima Memorial Hospital College of Medicine & Dentistry, Lahore, Pakistan
AH ALVI Department of Gastroenterology, Fatima Memorial Hospital, Lahore, Pakistan
M SOHAIB Department of Gastroenterology, Fatima Memorial Hospital College of Medicine & Dentistry, Lahore, Pakistan
S ALI Division of Infectious Diseases, Wayne State University, Datroit, Michigan, USA.
M ULFAT Department of Medicine, Fatima Memorial Hospital, Lahore, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.561

Keywords:

COVID-19, Infections, Persistence of Symptoms

Abstract

This study aimed to determine the frequency of persistent COVID-19 symptoms after recovery from the infection.

The study design was cross-sectional and conducted at the Department of Medicine, Fatima Memorial Hospital, Lahore. A non-probability consecutive sampling technique was employed, and the study duration was six months (from 28th June 2021 to 27th December 2021) after approval from the ethical committee. The sample size was 400. The study found that symptoms persisted for varying durations of less than one week, one to two weeks, two to four weeks, and more than four weeks. The most common persistent symptoms were lethargy (70.6%), body aches (55%), and cough (50%). The symptoms that persisted for more than four weeks were hair fall (71%), loss of smell and taste (53%), and body aches (43%). The mean duration of illness was two to four weeks from the start of the disease. The study concluded that COVID-19 infection was associated with residual symptoms that could persist for more than four weeks and affect patients' quality of life, interfering with daily life activities.

Downloads

Download data is not yet available.

References

Carfì, A., Bernabei, R., and Landi, F. (2020). Persistent symptoms in patients after acute COVID-19. Jama 324, 603-605.

Fjaeldstad, A. W. (2020). Prolonged complaints of chemosensory loss after COVID-19. Dan Med J 67, A05200340.

Garrigues, E., Janvier, P., Kherabi, Y., Le Bot, A., Hamon, A., Gouze, H., Doucet, L., Berkani, S., Oliosi, E., and Mallart, E. (2020). Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. Journal of Infection 81, e4-e6.

Ghosn, J., Piroth, L., Epaulard, O., Le Turnier, P., Mentré, F., Bachelet, D., and Laouénan, C. (2021). Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clinical Microbiology and Infection 27, 1041. e1-1041. e4.

Landi, F., Gremese, E., Rota, E., Benvenuto, F., Ciciarello, F., Monaco, M. R. L., Martone, A. M., Pagano, F., Paglionico, A., and Petricca, L. (2020). Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: when does quarantine really end? Journal of Infection 81, e1-e3.

Lechien, J. R., Chiesa‐Estomba, C. M., Place, S., Van Laethem, Y., Cabaraux, P., Mat, Q., Huet, K., Plzak, J., Horoi, M., and Hans, S. (2020). Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019. Journal of internal medicine 288, 335-344.

Righi, E., Mirandola, M., Mazzaferri, F., Dossi, G., Razzaboni, E., Zaffagnini, A., Ivaldi, F., Visentin, A., Lambertenghi, L., and Arena, C. (2022). Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study. Journal of Infection 84, 566-572.

Rodriguez-Morales, A. J., Cardona-Ospina, J. A., Gutiérrez-Ocampo, E., Villamizar-Peña, R., Holguin-Rivera, Y., Escalera-Antezana, J. P., Alvarado-Arnez, L. E., Bonilla-Aldana, D. K., Franco-Paredes, C., and Henao-Martinez, A. F. (2020). Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel medicine and infectious disease 34, 101623.

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., and Xiong, Y. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. jama 323, 1061-1069.

Whitaker, M., Elliott, J., Chadeau-Hyam, M., Riley, S., Darzi, A., Cooke, G., Ward, H., and Elliott, P. (2022). Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nature communications 13, 1957.

Zheng, K. I., Feng, G., Liu, W. Y., Targher, G., Byrne, C. D., and Zheng, M. H. (2021). Extrapulmonary complications of COVID‐19: A multisystem disease? Journal of Medical Virology 93, 323-335.